Back to Companies
Hepion Pharmaceuticals, Inc.
HEPAOTCCIK: 0001583771
Over the 26 most recent insider filings, Hepion Pharmaceuticals, Inc. (HEPA) has seen activity from 10 distinct insiders — all of them on the buy side. The activity is heavily weighted toward buying: $1.2M bought versus $0 sold, a net purchase of $1.2M. LoPriore Vincent S (Executive Chairman, Director) is the most active by dollar volume, and the single largest transaction was $1.1M by LoPriore Vincent S. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$3.5M
Purchases
$1.2M
Sales
$0
Unique Insiders
10
Recent Insider Trades
26 loaded
| Oct 2 | HEPA Hepion Pharmaceuticals, Inc. | Fisher Danina | Director | Buy | $10.0K |
| Sep 14 | HEPA Hepion Pharmaceuticals, Inc. | LoPriore Vincent S | Executive Chairman, Director | Other | $750.0K |
| Aug 21 | HEPA Hepion Pharmaceuticals, Inc. | Stetz Gary S. | Interim CEO, Director | Award | $107.6K |
| Aug 21 | HEPA Hepion Pharmaceuticals, Inc. | Appajosyula Sireesh | Chief Operating Officer, Director | Award | $107.6K |
| Aug 21 | HEPA Hepion Pharmaceuticals, Inc. | LoPriore Vincent S | Executive Chairman, Director | Award | $107.6K |
| Aug 21 | HEPA Hepion Pharmaceuticals, Inc. | Stetz Gary S. II | Director | Award | $23.9K |
| Aug 21 | HEPA Hepion Pharmaceuticals, Inc. | Liddy James Gordon | Director | Award | $23.9K |
| Aug 21 | HEPA Hepion Pharmaceuticals, Inc. | Fisher Danina | Director | Award | $23.9K |
| Aug 21 | HEPA Hepion Pharmaceuticals, Inc. | Liddy James Gordon | Director | Other | $0 |
| Sep 10 | HEPA Hepion Pharmaceuticals, Inc. | Purcell Michael J. | Director | Award | $23.9K |
| Aug 21 | HEPA Hepion Pharmaceuticals, Inc. | LoPriore Chase | VP, Corp. Dev., Director | Award | $107.6K |
| Aug 12 | HEPA Hepion Pharmaceuticals, Inc. | Appajosyula Sireesh | Chief Operating Officer, Director | Buy | $100.0K |
| Aug 12 | HEPA Hepion Pharmaceuticals, Inc. | Stetz Gary S. II | Director | Buy | $25.0K |
| Aug 12 | HEPA Hepion Pharmaceuticals, Inc. | LoPriore Vincent S | Executive Chairman, Director | Buy | $500.0K |
| Sep 16 | HEPA Hepion Pharmaceuticals, Inc. | KI Holdings, Ltd. | 10% Owner | Other | $0 |
| Aug 12 | HEPA Hepion Pharmaceuticals, Inc. | Stetz Gary S. | Interim CEO, Director | Buy | $100.0K |
| Aug 7 | HEPA Hepion Pharmaceuticals, Inc. | Black Global 5 LLC | 10% Owner | Other | $0 |
| Aug 12 | HEPA Hepion Pharmaceuticals, Inc. | Purcell Michael J. | Director | Buy | $100.0K |
| Jul 10 | HEPA Hepion Pharmaceuticals, Inc. | Stetz Gary S. II | Director | Other | $0 |
| Jul 8 | HEPA Hepion Pharmaceuticals, Inc. | Fisher Danina | Director | Other | $0 |
| Apr 27 | HEPA Hepion Pharmaceuticals, Inc. | Appajosyula Sireesh | Director | Buy | $50.0K |
| Apr 27 | HEPA Hepion Pharmaceuticals, Inc. | Stetz Gary S. | Interim CEO, Director | Buy | $50.0K |
| Apr 27 | HEPA Hepion Pharmaceuticals, Inc. | LoPriore Vincent S | Executive Chairman, Director, 10% Owner | Buy | $250.0K |
| Apr 27 | HEPA Hepion Pharmaceuticals, Inc. | Purcell Michael J. | Director | Buy | $50.0K |
| Mar 18 | HEPA Hepion Pharmaceuticals, Inc. | Appajosyula Sireesh | Director | Other | $0 |
| May 26 | HEPA Hepion Pharmaceuticals, Inc. | LoPriore Chase | Director | Other | $0 |
26 filings